Navigation Links
Drug Regimen Prevents AIDS Transmission Via Breast Milk

But limiting the time a mother nurses doesn't protect the baby, study finds

WEDNESDAY, June 4 (HealthDay News) -- Each year, an estimated 200,000 babies worldwide are infected with the AIDS virus through their mother's breast milk. Now, a new study suggests that a short-term drug regimen could provide significant protection for infants.

"It is very practical, and these drugs are relatively cheap. We believe a large proportion [of infants] can be protected," said study co-author Dr. Taha E. Taha, co-director of the infectious disease program at Johns Hopkins University's Bloomberg School of Public Health.

The problem of HIV transmission through breast milk is especially acute in sub-Saharan Africa, where mothers rarely use formula, Taha said, while it's not a significant problem in the United States.

The estimated 200,000 infants worldwide who get AIDS annually through breast milk make up a huge portion of the 500,000 new infections. (Babies can also get HIV about 10 percent of the time during gestation when a mother is infected, Taha said.)

One solution would be to discourage breast-feeding, but a number of challenges would make it difficult to replace breast-feeding with formula in parts of Africa, Taha said. Among other hurdles, the lack of clean water would make it impossible to sanitize bottles used for formula, he said.

Assuming that breast-feeding is unlikely to decline, Taha and his colleagues tested three drug regimens designed to prevent HIV transmission through breast milk. They tested the regimens on 3,016 infants in the African country of Malawi.

One regimen, known as the control group, included a single dose of the AIDS drug nevirapine (Viramune) plus one week of treatment with the drug zidovudine (AZT or Retrovir). The other regimens added daily doses of nevirapine or nevirapine as well as zidovudine until the age of 14 weeks.

The infants who took the control-group regimen had the highest rates of HIV infection from the age of 6 weeks to 18 months. At nine months, 11 percent of the control group infants were infected with the virus, compared to 5.2 and 6.4 percent, respectively, among the nevirapine and the nevirapine-plus-zidovudine groups.

The findings were published online Wednesday in the New England Journal of Medicine and were expected to be in the July 10 print issue of the journal.

Another study in the same issue of the journal found that stopping breast-feeding early and abruptly -- as early as four months after birth -- doesn't significantly lower the risk that infants will become infected with HIV.

About two-thirds of a group of infants in the African nation of Zambia whose mothers stopped breast-feeding before five months lived without developing HIV infection to the age of 24 moths. In another group, in which mothers breast-fed for an average of 16 months, about the same percentage lived for 24 months without becoming infected with HIV.

In a commentary accompanying the two studies, a pair of AIDS specialists in South Africa praised the research. But they wrote that more studies need to look at whether HIV transmission can be prevented by both extending drug treatment and shortening the time of breast-feeding.

Still, the findings of the second study suggest that "one should not stop breast-feeding in infants whose HIV status you don't know. Stopping breast-feeding in HIV-infected infants was harmful," said Glenda Gray, one of the commentary authors and director of the Perinatal HIV Research Unit at the University of Witwatersrand in Johannesburg.

More information

Learn more about breast-feeding and HIV from

SOURCES: Taha E. Taha, M.D., Ph.D., co-director, infectious disease program, Johns Hopkins University's Bloomberg School of Public Health, Baltimore; Glenda Gray, M.B., B.Ch., director, Perinatal HIV Research Unit at the University of Witwatersrand in Johannesburg, South Africa; July 10, 2008, New England Journal of Medicine

Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals
2. Study Supports Popular HIV Drug Regimen
3. Electronic Pillbox Helps Seniors Stick to Drug Regimens
4. Clinical Symptoms Enough to Switch Drug Regimens for HIV Patients
5. Trial finds tenofovir gel safe for daily use and most women adhered to study regimens
6. Study Shows MammaPrint(R) Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen
7. Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma
8. Different anticoagulant regimens yield equal results
9. New, No-Swallow Fasprin(R) Reduces Problems Associated with Daily Aspirin Regimen
10. Spate of Staph Infections Highlight the Need for Thorough, Consistent Cleaning Regimen at Home, at School and at Work
11. Multiple Sclerosis Patients Find Dietary Treatment More Effective Than Pharmaceutical Regimens
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... The ... prided itself for not only fulfilling the needs of advisers and clients but ... affordable price and providing top-tier customer service. However, there's always room for improvement, ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... largest, most successful and prominent nonprofit healthcare organizations in the country. They have ... with various organizations, and helped advance the healthcare industry as a whole through ...
(Date:11/27/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk ... Term Support) into its Q-Suite 5.10 product line. , Making the change to ... of Asterisk that will receive not only security fixes, but feature and bug ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD and Cambridge Memorial ... in the Waterloo region. Using the Ocean Platform, family physicians can now order ... electronic medical record (EMR) without the need for redundant patient entry or an ...
(Date:11/26/2015)... ... November 26, 2015 , ... Jobs in hospital medical laboratories and in the ... healthcare staffing agency Aureus Medical Group . These fields, as well ... those searching for healthcare jobs through the company’s website, , The ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
(Date:11/25/2015)... 25, 2015 ... the "Global Brain Monitoring Devices Market ... --> ) has announced the ... Devices Market 2015-2019" report to their ... ( ) has announced the addition ...
Breaking Medicine Technology: